SEARCH

SEARCH BY CITATION

References

  • 1
    Das Gupta BR. Structure and biological activity of botulinum neurotoxin. J. Physiolz 1990; 84: 220 8.
  • 2
    Montecucco C, ed. Clostridium Neurotoxins. The Molecular Pathogenesis of Tetanus and Botulism: Current Topics in Microbiology and Immunology. 1995: 195.
  • 3
    Jankovic J & Brin MF. Therapeutic uses of botulinum toxin. N Engl J Med 1991; 324: 1186 94.
  • 4
    Jankovic J & Hallet M, eds. Therapy with Botulinum Toxin. 1994.
  • 5
    Cullen JJ & Kelly KA. Motility disorders of the gastrointestinal tract: Gastric motor physiology and pathophysiology. Surg Clin North Am 1993; 73: 1145 60.
  • 6
    Press WH, Teukolsky SA, Vetterling WT, et al. Numerical Recipes in C. The Art of Scientific Computing. Cambridge: Cambridge University Press, 1993.
  • 7
    Schiavo G, Rossetto O, Benfenati F, et al. Tetanus and botulinum neurotoxins are zinc proteases specific for components of the neuroexocytosis apparatus Ann NY Acad Sci 1994; 710: 65 75.
  • 8
    Albanese A, Bentivoglio M, Cassetta E, et al. Review article: the use of Botulinum Toxin in the alimentary tract Aliment Pharmacol Ther 1995; 9: 599 604.
  • 9
    Albanese A, Bentivoglio M, Cassetta E, et al. The use of Botulinum Toxin on smooth muscles Eur J Neurol 1995; 2: 1 5.
  • 10
    Parisha PJ & Ravich WJ. Intra-sphyncteric botulinum toxin for the treatment of achalasia. N Engl J Med 1995; 23: 774 8.
  • 11
    Parisha PJ, Ravich WJ, Kalloo AN. Botulinum toxin for achalasia. Lancet 1993; 341: 244 5.
  • 12
    Gui D, Cassetta E, Anastasio G, et al. Botulinum toxin for chronic anal fissure Lancet 1994; 344: 1127 8.
  • 13
    Hutson WR & Wals A. Obesity and weight reduction do not influence gastric emptying and antral motility. Am J Gastroenterology 1993; 88: 1405 09.
  • 14
    Pappas TN. Physiological satiety implications of gastro-intestinal anti-obesity surgery. Am J Clin Nutr 1992; 55: 571S 72S.